Translation of cancer immunotherapies

Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. doi: 10.1038/nm1104-1153a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Academic Medical Centers
  • Drug Approval / methods*
  • Drug Approval / organization & administration
  • Drug Combinations
  • Drug Industry
  • Government Regulation
  • Humans
  • Immunotherapy / methods
  • Immunotherapy / trends*
  • Interinstitutional Relations
  • National Institutes of Health (U.S.)
  • Neoplasms / therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Drug Combinations